Zhipeng Li
- Molecular Biology
- Biomaterials top 10%
- Biomedical Engineering
- Cancer Research
- Molecular Medicine top 10%
- Co-authors
- Jingliang WuBo ZhangYong SunGuixiang TianHong JiangRuiyan PanJianqin YanHongli Yu
- Topics
- Nanoplatforms for cancer theranostics (9 papers)Nanoparticle-Based Drug Delivery (7 papers)Retinal Diseases and Treatments (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhipeng Li
35 papers receiving 528 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 190
- Biomaterials 145
- Biomedical Engineering 144
- Cancer Research 47
- Molecular Medicine 43
Countries citing papers authored by Zhipeng Li
This map shows the geographic impact of Zhipeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Li more than expected).
Fields of papers citing papers by Zhipeng Li
This network shows the impact of papers produced by Zhipeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Li. The network helps show where Zhipeng Li may publish in the future.
Co-authorship network of co-authors of Zhipeng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Li. A scholar is included among the top collaborators of Zhipeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Li. Zhipeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 13 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 14 | |
| 8 | 7 | |
| 9 | 41 | |
| 10 | 18 | |
| 11 | 11 | |
| 12 | 10 | |
| 13 | 26 | |
| 14 | 48 | |
| 15 | 15 | |
| 16 | 29 | |
| 17 | 45 | |
| 18 | 5 | |
| 19 | 12 | |
| 20 | [Mechanism of conditioned immune response in curing bronchial asthma in mice]. | 0 |
About Zhipeng Li
Zhipeng Li is a scholar working on Biomaterials, Molecular Medicine and Biotechnology, having authored 38 papers that have together received 534 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Biomaterials (145 citations), Molecular Medicine (43 citations) and Pharmaceutical Science (32 citations). Zhipeng Li has collaborated with scholars based in China and United States. Frequent co-authors include Jingliang Wu, Bo Zhang, Yong Sun, Guixiang Tian, Hong Jiang, Ruiyan Pan, Jianqin Yan, Hongli Yu, Shangcong Han and Ning Fang. Their work appears in journals such as Biomaterials, Bioresource Technology and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.